Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
48,760,367
-
Share change
-
+11,236,473
-
Total reported value
-
$777,639,832
-
Put/Call ratio
-
106%
-
Price per share
-
$15.95
-
Number of holders
-
151
-
Value change
-
+$198,323,811
-
Number of buys
-
85
-
Number of sells
-
81
Institutional Holders of DIPLOMAT PHARMACY INC - COM (DPLO) as of Q1 2017
As of 31 Mar 2017,
DIPLOMAT PHARMACY INC - COM (DPLO) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,760,367 shares.
The largest 10 holders included
BlackRock Inc., FRONTIER CAPITAL MANAGEMENT CO LLC, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BALYASNY ASSET MANAGEMENT LLC, HERMES INVESTMENT MANAGEMENT LTD, CITADEL ADVISORS LLC, DAVIS SELECTED ADVISERS, RIVERBRIDGE PARTNERS LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
151
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.